Gurgaon (Haryana) [India], May 12 (ANI/BusinessWire India): Art of Healing Cancer, one of the leading organizations focused on precision oncology to treat cancer patients, is raising awareness about the high cost of immunotherapy treatment in India by sharing important information on the sub
Scientists at St. Jude Children's Research Hospital researched the effect of their environment to acquire a better grasp of the disparities between juvenile cancer patients when it comes to the effects of radiation therapy on cognition. Their research found that children who grew up in suppo
A recent study suggested that spinal cord stimulation (SCS) may be effective in lowering chronic pain in persons receiving active therapy with a standard anti-cancer medicine, according to researchers at Johns Hopkins University School of Medicine.
The survival rate for people with advanced bladder cancer is less than a year, making it the fourth most common cancer diagnosed in men. The bladder cancer patients who will benefit from immunotherapy are unknown to doctors.
A novel cell signalling route was discovered by researchers at the Johns Hopkins Kimmel Cancer Centre that may one day be used as a therapeutic target for people with aggressive pancreatic cancer.
A startling 89 per cent of desmoplastic melanoma patients in a nationwide clinical study responded to immunotherapy (pembrolizumab) alone, indicating that many patients could avoid the potential side effects of combination therapies and achieve disease control with this course of treatment.
Immune Checkpoint Blockade, or ICB therapy, has become the gold standard for treating lung cancer because of its frequently successful results. High levels of the PD-L1 protein have served as the main indicator of a favourable response to treatment up until now
According to a study, a novel medication called enoblituzumab, a monoclonal antibody, is safe in men with aggressive prostate cancer and may promote clinical action against cancer across the body.
According to new research, a biomarker signature can predict how well kidney cancer patients will respond to immunotherapy before treatment even starts. This biomarker signature is made up of the number of immune cells in and around kidney tumours, the volume of dead cancer tissue, and mutat
A team from UNIGE has created a novel technique for testing various medications without using animals or the body of the patient. Organoids, which are tiny replicas of organs and tissues made from patients exposed to therapies, were used by the researchers
Despite the fact that chimeric antigen receptor T-cell (CAR-T) therapy has transformed cancer treatment, few studies have looked into its impact on long-term patient quality of life - an aspect of care that is frequently compromised when patients receive traditional intensive cancer medicati